A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a CKD-330 Versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 04 Oct 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2016.
- 15 Jul 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.